|Articles|March 19, 2020
Oncology Product Manufacturing in a Nondedicated Facility
Author(s)Baxter BioPharma Solutions
- Advantages of manufacturing immuno-oncology therapies in multiproduct facilities - Preventing cross-contamination and proper cleaning validation
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
From AI to Smart Factories: How Pharma Is Preparing for 2026
2
Genetic Medicines Project Gets Funding from UKRI Innovate UK and Canadian NRC IRAP
3
Industry Outlook 2026: Success through Top Talent, AI Utilization, and Sustainability
4
FUJIFILM Irvine Scientific Becomes FUJIFILM Biosciences
5